Netherlands· NL-66f380048e26
Methyldopa CF 250 mg, tabletten
A methyldopa (levorotatory) product containing methyldopa 1,5-water, registered in Netherlands by Centrafarm B.V.. The same ATC class is registered in 10 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Methyldopa (levorotatory) is registered in 10 of 19 countries.
Countries holding a registration under ATC C02AB01 (methyldopa (levorotatory)), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 7 of them publish a price we can compare per daily dose
Methyldopa (levorotatory) · ATC C02AB01
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of methyldopa (levorotatory) costs, country by country.
Normalised to the WHO defined daily dose (1 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Methyldopa (levorotatory) · price per daily dose (1 g)
USD · FX 28 Sept 2026
- IT Italy$0.42
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- METHYLDOPA 1,5-WATER
- Manufacturer
- Centrafarm B.V.
- Country
- Netherlands (NL)
- ATC code
- C02AB01
- ATC class
- Methyldopa (levorotatory)
- Defined daily dose
- 1 g, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id57522
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
182 interactions on record for methyldopa (levorotatory).
Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Methyldopa (levorotatory) · interactions on record
182 records
- 8 severe
- 95 moderate
- 10 minor
- 69 info
Most severe, free to view
- ProcarbazineL01XB01severe
- LeflunomidL04AA13severe
- TeriflunomidL04AA31severe
- OzanimodL04AA38severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Methyldopa (levorotatory) in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAldomet 250mg tabletsSigma Pharmaceuticals Plc
- PolandDopegytDelfarma Sp. z o.o.
- NorwayAldometAspen Global Health and Development
- CzechiaDOPEGYTEgis Pharmaceuticals PLC, Budapešť
- FinlandSembrinaOrion Corporation Orion Pharma
- CanadaMETHYLDOPAAA PHARMA INC
- United StatesMethyldopaRising Pharma Holdings, Inc.
- GermanyDopegytCheplapharm Arzneimittel Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Austria · Aldometil
- Belgium · Aldomet
- Bulgaria · Допегит
- Cyprus · Dopamet, Methyldopa Remedica
- Czechia · Dopegyt
- Germany · Dopegyt, Methyldopa Stada
- Denmark · Methyldopa Macure
- Spain · Aldomet, Aldomet Forte
- Finland · Methyldopa Macure
- France · Aldomet
- United Kingdom (Northern Ireland) · Methyldopa, Methyldopa Accord-Uk
- Hungary · Dopegyt
- Italy · Aldomet
- Lithuania · Dopegyt
- Latvia · Dopegyt
- Malta · Methyldopa Remedica
- Norway · Methyldopa Macure
- Poland · Dopegyt
- Portugal · Aldomet, Aldomet Forte
- Romania · Dopegyt
- Sweden · Methyldopa Macure
- Slovakia · Dopegyt
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/46cce1f0-4985-4a4e-a9a6-8287b57e7b35 GET /v1/drugs/46cce1f0-4985-4a4e-a9a6-8287b57e7b35?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h57522_smpc.pdf",
"strength": null,
"atc_label": "Methyldopa (Levorotatory)",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg57522",
"excipients": [
"CELLULOSE, MICROKRISTALLIJN (E 460(i))",
"CHINOLINEGEEL (E 104)",
"ETHYLCELLULOSE (E 462)",
"HYPROMELLOSE (E 464)",
"MAGNESIUMSTEARAAT (E 470b)",
"NATRIUMZETMEELGLYCOLAAT",
"PROPYLEENGLYCOL (E 1520)",
"SILICIUMDIOXIDE (E 551)",
"TALK (E 553b)",
"TITAANDIOXIDE (E 171)",
"ZONNEGEEL FCF (E 110)"
],
"substances": [
"METHYLDOPA 1,5-WATER"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h57522.pdf",
"authorised_at": "1991/04/29",
"procedure_number": null,
"dispensing_status": "Uitsluitend recept",
"registration_number": "57522",
"additional_monitoring": "N"
}See everything about methyldopa (levorotatory).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.